Therapeutic Delivery Specifications Identified Through Compartmental Analysis of a Mesenchymal Stromal Cell-Immune Reaction

Despite widespread preclinical success, mesenchymal stromal cell (MSC) therapy has not reached consistent pivotal clinical endpoints in primary indications of autoinflammatory diseases. Numerous studies aim to uncover specific mechanisms of action towards better control of therapy using in vitro imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Matthew, Khong, Danika, Chin, Ling-Yee, Singleton, Amy, Parekkadan, Biju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931547/
https://www.ncbi.nlm.nih.gov/pubmed/29717209
http://dx.doi.org/10.1038/s41598-018-24971-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931547/
https://www.ncbi.nlm.nih.gov/pubmed/29717209
http://dx.doi.org/10.1038/s41598-018-24971-2

Ejemplares similares